Please find enclosed the voting results on the business transacted at the Extraordinary General Meeting of the Company held on Monday, 11th August 2025 through video conferencing / other ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries has submitted the voting results of its Extraordinary General Meeting (EGM) held on Monday, 11th August 2025 at 1:00 p.m. through video conferencing, as required under Regulation 44(3) of the SEBI Listing Regulations. The filing was made to BSE (Scrip Code: 543828) on 12th August 2025 and signed by Hemal Mehta, Chairman & Managing Director. The document encloses the voting outcome on the business transacted at the meeting, though the detailed resolution-wise voting breakdown table was not clearly readable in the submitted copy. No resolutions or special business items are explicitly mentioned in the legible portion of the filing.
Routine regulatory disclosure — shareholders can review the EGM voting outcomes to confirm approval of any special business. No direct price-moving impact expected unless the resolutions involved capital raising, M&A, or major policy changes, which are not visible in the submitted text.